304 related articles for article (PubMed ID: 24768741)
21. Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons.
McClymont SA; Hook PW; Soto AI; Reed X; Law WD; Kerans SJ; Waite EL; Briceno NJ; Thole JF; Heckman MG; Diehl NN; Wszolek ZK; Moore CD; Zhu H; Akiyama JA; Dickel DE; Visel A; Pennacchio LA; Ross OA; Beer MA; McCallion AS
Am J Hum Genet; 2018 Dec; 103(6):874-892. PubMed ID: 30503521
[TBL] [Abstract][Full Text] [Related]
22. Parkinson patient fibroblasts show increased alpha-synuclein expression.
Hoepken HH; Gispert S; Azizov M; Klinkenberg M; Ricciardi F; Kurz A; Morales-Gordo B; Bonin M; Riess O; Gasser T; Kögel D; Steinmetz H; Auburger G
Exp Neurol; 2008 Aug; 212(2):307-13. PubMed ID: 18511044
[TBL] [Abstract][Full Text] [Related]
23. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
Rutherford NJ; Moore BD; Golde TE; Giasson BI
J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of SNCA coding mutation in Chinese Han patients with Parkinson disease.
Deng S; Deng X; Yuan L; Song Z; Yang Z; Xiong W; Deng H
Acta Neurol Belg; 2015 Sep; 115(3):267-71. PubMed ID: 25092551
[TBL] [Abstract][Full Text] [Related]
25. Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.
Rajput A; Vilariño-Güell C; Rajput ML; Ross OA; Soto-Ortolaza AI; Lincoln SJ; Cobb SA; Heckman MG; Farrer MJ; Rajput A
Mov Disord; 2009 Dec; 24(16):2411-4. PubMed ID: 19890971
[TBL] [Abstract][Full Text] [Related]
26. Alpha-synuclein A30P point-mutation generates age-dependent nigrostriatal deficiency in mice.
Plaas M; Karis A; Innos J; Rebane E; Baekelandt V; Vaarmann A; Luuk H; Vasar E; Koks S
J Physiol Pharmacol; 2008 Jun; 59(2):205-16. PubMed ID: 18622040
[TBL] [Abstract][Full Text] [Related]
27. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of α-synuclein gene in Parkinson's disease in North Karnataka, India.
Kadakol GS; Kulkarni SS; Wali GM; Gai PB
Neurol India; 2014; 62(2):149-52. PubMed ID: 24823723
[TBL] [Abstract][Full Text] [Related]
29. A Drosophila model of Parkinson's disease.
Feany MB; Bender WW
Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
[TBL] [Abstract][Full Text] [Related]
30. Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans.
Kuwahara T; Koyama A; Gengyo-Ando K; Masuda M; Kowa H; Tsunoda M; Mitani S; Iwatsubo T
J Biol Chem; 2006 Jan; 281(1):334-40. PubMed ID: 16260788
[TBL] [Abstract][Full Text] [Related]
31. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
Cabin DE; Gispert-Sanchez S; Murphy D; Auburger G; Myers RR; Nussbaum RL
Neurobiol Aging; 2005 Jan; 26(1):25-35. PubMed ID: 15585343
[TBL] [Abstract][Full Text] [Related]
32. SNCA: major genetic modifier of age at onset of Parkinson's disease.
Brockmann K; Schulte C; Hauser AK; Lichtner P; Huber H; Maetzler W; Berg D; Gasser T
Mov Disord; 2013 Aug; 28(9):1217-21. PubMed ID: 23674386
[TBL] [Abstract][Full Text] [Related]
33. Blood RNA biomarkers in prodromal PARK4 and rapid eye movement sleep behavior disorder show role of complexin 1 loss for risk of Parkinson's disease.
Lahut S; Gispert S; Ömür Ö; Depboylu C; Seidel K; Domínguez-Bautista JA; Brehm N; Tireli H; Hackmann K; Pirkevi C; Leube B; Ries V; Reim K; Brose N; den Dunnen WF; Johnson M; Wolf Z; Schindewolf M; Schrempf W; Reetz K; Young P; Vadasz D; Frangakis AS; Schröck E; Steinmetz H; Jendrach M; Rüb U; Başak AN; Oertel W; Auburger G
Dis Model Mech; 2017 May; 10(5):619-631. PubMed ID: 28108469
[TBL] [Abstract][Full Text] [Related]
34. α-Synuclein and Parkinsonism: Updates and Future Perspectives.
Rosborough K; Patel N; Kalia LV
Curr Neurol Neurosci Rep; 2017 Apr; 17(4):31. PubMed ID: 28324300
[TBL] [Abstract][Full Text] [Related]
35. Progress in the pathogenesis and genetics of Parkinson's disease.
Mizuno Y; Hattori N; Kubo S; Sato S; Nishioka K; Hatano T; Tomiyama H; Funayama M; Machida Y; Mochizuki H
Philos Trans R Soc Lond B Biol Sci; 2008 Jun; 363(1500):2215-27. PubMed ID: 18426756
[TBL] [Abstract][Full Text] [Related]
36. Reduction of the α-synuclein expression promotes slowing down early neuropathology development in the
Golomidov IM; Latypova EM; Ryabova EV; Bolshakova OI; Komissarov AE; Sarantseva SV
J Neurogenet; 2022 Mar; 36(1):1-10. PubMed ID: 35467466
[TBL] [Abstract][Full Text] [Related]
37. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease.
Ross OA; Gosal D; Stone JT; Lincoln SJ; Heckman MG; Irvine GB; Johnston JA; Gibson JM; Farrer MJ; Lynch T
Mech Ageing Dev; 2007; 128(5-6):378-82. PubMed ID: 17531291
[TBL] [Abstract][Full Text] [Related]
38. Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.
Guhathakurta S; Bok E; Evangelista BA; Kim YS
Prog Neurobiol; 2017 Jul; 154():21-36. PubMed ID: 28445713
[TBL] [Abstract][Full Text] [Related]
39. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
Nishioka K; Hayashi S; Farrer MJ; Singleton AB; Yoshino H; Imai H; Kitami T; Sato K; Kuroda R; Tomiyama H; Mizoguchi K; Murata M; Toda T; Imoto I; Inazawa J; Mizuno Y; Hattori N
Ann Neurol; 2006 Feb; 59(2):298-309. PubMed ID: 16358335
[TBL] [Abstract][Full Text] [Related]
40. A population scale analysis of rare SNCA variation in the UK Biobank.
Blauwendraat C; Makarious MB; Leonard HL; Bandres-Ciga S; Iwaki H; Nalls MA; Noyce AJ; Singleton AB
Neurobiol Dis; 2021 Jan; 148():105182. PubMed ID: 33307186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
